SUNPHARMA.NSSUNPHARMA.NSNSE

Revenue (LTM)

$525.8B

+8.4% YoY

Net Income (LTM)

$109.3B

+14.1% YoY

Free Cash Flow

$119.4B

Revenue CAGR (5Y)

+9.9%

Marginsimproving

FCF$119.4B

Profitable

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Revenue	334,981	386,545↑15.4%	438,857↑13.5%	484,969↑10.5%	525,784↑8.4%
Gross Profit	242,796	277,784↑14.4%	325,670↑17.2%	370,547↑13.8%	410,200↑10.7%
Operating Income	152,726	182,915↑19.8%	219,044↑19.8%	244,245↑11.5%	278,149↑13.9%
Net Income	29,038	32,727↑12.7%	84,736↑158.9%	95,764↑13.0%	109,290↑14.1%
EBITDA	83,451	101,536↑21.7%	116,513↑14.8%	128,760↑10.5%	149,679↑16.2%
EPS Diluted	12.10	13.64↑12.7%	35.32↑158.9%	39.91↑13.0%	45.60↑14.3%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Cash & Equivalents	62,730	45,083↓28.1%	46,237↑2.6%	92,857↑100.8%	113,316↑22.0%
Total Current Assets	304,421	350,150↑15.0%	398,619↑13.8%	434,331↑9.0%	526,245↑21.2%
Total Assets	676,667	697,999↑3.2%	807,436↑15.7%	854,629↑5.8%	921,006↑7.8%
Total Current Liabilities	161,456	172,006↑6.5%	199,064↑15.7%	169,844↓14.7%	181,942↑7.1%
Total Liabilities	181,869	187,338↑3.0%	214,281↑14.4%	183,569↓14.3%	196,146↑6.9%
Total Equity	464,628	480,112↑3.3%	559,954↑16.6%	636,668↑13.7%	722,180↑13.4%
Total Debt	38,686	12,903↓66.6%	68,897↑434.0%	32,737↓52.5%	23,622↓27.8%
Net Debt	-24,045	-32,180↓33.8%	22,659↑170.4%	-60,120↓365.3%	-89,694↓49.2%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Operating Cash Flow	61,704	89,845↑45.6%	49,593↓44.8%	121,350↑144.7%	140,721↑16.0%
Capital Expenditure	-11,701	-14,950↓27.8%	-20,856↓39.5%	-22,018↓5.6%	-21,286↑3.3%
Free Cash Flow	50,002	74,895↑49.8%	28,738↓61.6%	99,332↑245.7%	119,435↑20.2%
Stock-Based Comp	0	0	0	0	0
Net Change in Cash	5,964	-17,648↓395.9%	1,155↑106.5%	46,619↑3937.0%	9,831↓78.9%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance